| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Taxes paid related to net settled equity awards | 250 | 250 |
| Net cash provided by financing activities | 93,856 | 94,054 |
| Net decrease in cash and cash equivalents | -16,459 | 13,369 |
| Effect of exchange rate changes on cash | 330 | - |
| Cash and cash equivalents at beginning of period | 250,867 | - |
| Cash and cash equivalents at end of period | 234,738 | - |
ADC Therapeutics SA (ADCT)
ADC Therapeutics SA (ADCT)